Zydus Lifesciences Limited — Others, 10-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Zydus Lifesciences has announced a board meeting to consider the financial results for the quarter and half-year. The company confirmed that equity share certificates received for dematerialization during the quarter were verified, mutilated, and cancelled, with the depositories recorded as the registered owners. These dematerialized shares continue to be listed on both BSE and NSE, ensuring seamless trading and ownership transfer for shareholders. This update reflects ongoing compliance and smooth handling of share dematerialization, supporting investor confidence in the company’s equity management.